Free tool
FAERS Monitor: Delestrogen
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 009402 or its brand name (Delestrogen, Estradiol Valerate). Reports on generic versions are filed under their own applications.
Reports
778
Serious
525
67% of reports
Hospitalization
149
Death reported
19
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use96
- headache72
- drug ineffective71
- fatigue65
- nausea59
- pain53
- migraine45
- dyspnoea42
- weight increased39
- diarrhoea36
- abdominal pain30
- anxiety30
- arthralgia30
- dizziness30
- product quality issue30
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 14 |
| 2005 | 10 |
| 2006 | 10 |
| 2007 | 21 |
| 2008 | 17 |
| 2009 | 13 |
| 2010 | 22 |
| 2011 | 18 |
| 2012 | 39 |
| 2013 | 11 |
| 2014 | 27 |
| 2015 | 20 |
| 2016 | 28 |
| 2017 | 28 |
| 2018 | 62 |
| 2019 | 28 |
| 2020 | 47 |
| 2021 | 55 |
| 2022 | 52 |
| 2023 | 58 |
| 2024 | 65 |
| 2025 | 77 |
| 2026 | 56 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,381 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| migraineSignal | 45 | 12.7 | 9.6 | 478 |
| product quality issueSignal | 30 | 6.0 | 4.2 | 120 |
| weight increasedSignal | 39 | 4.7 | 3.5 | 111 |
| abdominal painSignal | 30 | 3.5 | 2.5 | 51 |
| headacheSignal | 72 | 3.1 | 2.5 | 104 |
| off label useSignal | 96 | 3.0 | 2.5 | 128 |
| anxietySignal | 30 | 2.9 | 2.0 | 35 |
| painSignal | 53 | 2.3 | 1.8 | 40 |
| fatigueSignal | 65 | 2.3 | 1.8 | 46 |
| nauseaSignal | 59 | 2.0 | 1.6 | 30 |
| dyspnoeaSignal | 42 | 2.0 | 1.5 | 21 |
| arthralgia | 30 | 2.0 | 1.4 | 13 |
| dizziness | 30 | 1.6 | 1.1 | 7 |
| diarrhoea | 36 | 1.5 | 1.1 | 6 |
| drug ineffective | 71 | 1.5 | 1.2 | 10 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.